Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 7.2913.6213.9814.462.89

What is the latest Core EBITDA Margin ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of BAFNA PHARMACEUTICALS is 7.29 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20247.29
Mar202313.62
Mar202213.98
Mar202114.46
Mar20202.89

How is Core EBITDA Margin of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 7.29
-46.48
Mar2023 13.62
-2.58
Mar2022 13.98
-3.32
Mar2021 14.46
400.35
Mar2020 2.89 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹192.0 Cr 1.3% 1.3% -8.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

1.3%

1.3%

-8.9%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses